These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 25204767)

  • 1. Design and evaluation of injectable niclosamide nanocrystals prepared by wet media milling technique.
    Ye Y; Zhang X; Zhang T; Wang H; Wu B
    Drug Dev Ind Pharm; 2015; 41(9):1416-24. PubMed ID: 25204767
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preparation and in vitro antitumor effects on MDA-MB-231 cells of niclosamide nanocrystals stabilized by poloxamer188 and PBS.
    Fu Q; Jin X; Zhang Z; Lv H
    Int J Pharm; 2020 Jun; 584():119432. PubMed ID: 32442644
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Toward Repositioning Niclosamide for Antivirulence Therapy of Pseudomonas aeruginosa Lung Infections: Development of Inhalable Formulations through Nanosuspension Technology.
    Costabile G; d'Angelo I; Rampioni G; Bondì R; Pompili B; Ascenzioni F; Mitidieri E; d'Emmanuele di Villa Bianca R; Sorrentino R; Miro A; Quaglia F; Imperi F; Leoni L; Ungaro F
    Mol Pharm; 2015 Aug; 12(8):2604-17. PubMed ID: 25974285
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development and characterization of lecithin stabilized glibenclamide nanocrystals for enhanced solubility and drug delivery.
    Kumar BS; Saraswathi R; Kumar KV; Jha SK; Venkates DP; Dhanaraj SA
    Drug Deliv; 2014 May; 21(3):173-84. PubMed ID: 24102185
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elucidating the in vivo fate of nanocrystals using a physiologically based pharmacokinetic model: a case study with the anticancer agent SNX-2112.
    Dong D; Wang X; Wang H; Zhang X; Wang Y; Wu B
    Int J Nanomedicine; 2015; 10():2521-35. PubMed ID: 25848269
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Brinzolamide nanocrystal formulations for ophthalmic delivery: reduction of elevated intraocular pressure in vivo.
    Tuomela A; Liu P; Puranen J; Rönkkö S; Laaksonen T; Kalesnykas G; Oksala O; Ilkka J; Laru J; Järvinen K; Hirvonen J; Peltonen L
    Int J Pharm; 2014 Jun; 467(1-2):34-41. PubMed ID: 24680962
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optimization of formulation and process parameters for the production of nanosuspension by wet media milling technique: effect of Vitamin E TPGS and nanocrystal particle size on oral absorption.
    Ghosh I; Schenck D; Bose S; Ruegger C
    Eur J Pharm Sci; 2012 Nov; 47(4):718-28. PubMed ID: 22940548
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bexarotene nanocrystal-Oral and parenteral formulation development, characterization and pharmacokinetic evaluation.
    Chen L; Wang Y; Zhang J; Hao L; Guo H; Lou H; Zhang D
    Eur J Pharm Biopharm; 2014 May; 87(1):160-9. PubMed ID: 24333772
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmaceutical and pharmacokinetic characteristics of different types of fenofibrate nanocrystals prepared by different bottom-up approaches.
    Zhang H; Meng Y; Wang X; Dai W; Wang X; Zhang Q
    Drug Deliv; 2014 Dec; 21(8):588-94. PubMed ID: 24320001
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design, Optimization, and Evaluation of Lurasidone Hydrochloride Nanocrystals.
    Shah S; Parmar B; Soniwala M; Chavda J
    AAPS PharmSciTech; 2016 Oct; 17(5):1150-8. PubMed ID: 26586537
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Niclosamide: an established antihelminthic drug as a potential therapy against S100A4-mediated metastatic colon tumors.
    Helfman DM
    J Natl Cancer Inst; 2011 Jul; 103(13):991-2. PubMed ID: 21685360
    [No Abstract]   [Full Text] [Related]  

  • 12. Controlled delivery of bPEI-niclosamide complexes by PEO nanofibers and evaluation of its anti-neoplastic potentials.
    Kumar SU; Gopinath P
    Colloids Surf B Biointerfaces; 2015 Jul; 131():170-81. PubMed ID: 25988281
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Studies on the preparation, characterization and pharmacokinetics of Amoitone B nanocrystals.
    Hao L; Wang X; Zhang D; Xu Q; Song S; Wang F; Li C; Guo H; Liu Y; Zheng D; Zhang Q
    Int J Pharm; 2012 Aug; 433(1-2):157-64. PubMed ID: 22579996
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Significantly enhanced bioavailability of niclosamide through submicron lipid emulsions with or without PEG-lipid: a comparative study.
    Zhang X; Zhang Y; Zhang T; Zhang J; Wu B
    J Microencapsul; 2015; 32(5):496-502. PubMed ID: 26079596
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Formulation, optimization and in vitro-in vivo evaluation of febuxostat nanosuspension.
    Ahuja BK; Jena SK; Paidi SK; Bagri S; Suresh S
    Int J Pharm; 2015 Jan; 478(2):540-52. PubMed ID: 25490182
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Octenylsuccinate hydroxypropyl phytoglycogen enhances the solubility and in-vitro antitumor efficacy of niclosamide.
    Xie Y; Yao Y
    Int J Pharm; 2018 Jan; 535(1-2):157-163. PubMed ID: 29113805
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autophagy-Inducing Inhalable Co-crystal Formulation of Niclosamide-Nicotinamide for Lung Cancer Therapy.
    Ray E; Vaghasiya K; Sharma A; Shukla R; Khan R; Kumar A; Verma RK
    AAPS PharmSciTech; 2020 Sep; 21(7):260. PubMed ID: 32944787
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preparation and antitumor study of camptothecin nanocrystals.
    Zhang H; Hollis CP; Zhang Q; Li T
    Int J Pharm; 2011 Aug; 415(1-2):293-300. PubMed ID: 21679755
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Redox-sensitive nanoparticles based on xylan-lipoic acid conjugate for tumor targeted drug delivery of niclosamide in cancer therapy.
    Sauraj ; Kumar A; Kumar B; Kulshreshtha A; Negi YS
    Carbohydr Res; 2021 Jan; 499():108222. PubMed ID: 33401229
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preparation and physicochemical properties of niclosamide anhydrate and two monohydrates.
    van Tonder EC; Maleka TS; Liebenberg W; Song M; Wurster DE; de Villiers MM
    Int J Pharm; 2004 Jan; 269(2):417-32. PubMed ID: 14706253
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.